Niacin as a novel therapy for septic shock?
Amar
A
Kapoor
Christoph
C
Thiemermann
D000818:Animals; D004195:Disease Models, Animal; D015536:Down-Regulation; D019446:Endotoxemia / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D016328:NF-kappa B / Q000187:drug effects*; D009525:Niacin / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D051381:Rats; D012680:Sensitivity and Specificity; D012772:Shock, Septic / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D015398:Signal Transduction; D015996:Survival Rate; D016896:Treatment Outcome
D016328:NF-kappa B; D009525:Niacin